Patent 7253164 was granted and assigned to IRM on August, 2007 by the United States Patent and Trademark Office.
This invention is directed to novel bicyclic compounds, to the uses of these compounds in various medicinal applications, including treating disorders amenable to treatment by peptidyl deformylase inhibitors such as treatment of bacterial infections, and to pharmaceutical compositions comprising these compounds.